Category Archives: Gail Naughton

Histogen’s Update from the Stem Cell on the Mesa Conference

Histogen’s excellent presentation from the Stem Cell on the Mesa Conference is finally available online and I have embedded the youtube video at the end of this post (hair loss related presentation is just under 3 minutes long).  Thanks to “Noisette” for letting me know about this in one of the comments under the above linked post, as well as to “the X” for letting me know in the hair loss chat. Also see Histogen’s presentation from last year.

I am not surprised about Histogen’s decision to get their final clinical trial for its male pattern baldness product done in Japan in early 2015, especially after Shiseido (aka Replicel) announced their intention to start trials in Japan during the first half of 2015.  Since starting this blog, I have frequently discussed the high likelihood of hair loss cures becoming approved in heavily populous Asia before anywhere else in the world, but I always thought that experiments, trials and approvals would be spread across the region, especially in developing countries such as China, India and Thailand. It is truly a wonderful surprise to instead see developed technologically advanced Japan dominating this sphere.

Histogen’s Hair Stimulating Complex (HSC) product seems to be significantly better than Replicel’s product as far as increase in long-term terminal hair counts go, although it was not entirely clear to me whether Replicel’s results were based on using a very low dosage or not, and how much better the results would be with higher doses assuming safety was not compromised.  Histogen’s results indicate efficacy in all areas of the scalp as well as on people over the age of 40.

For the female readers of this blog, the below video also shows that this treatment works for women too!  Although Histogen’s clinical trials (in the US) for women’s hair loss are well behind the trials for men’s hair loss, I wonder if women will be able to access the men’s product (administered via injections) as soon as it is approved and comes out?

FYI — US and EU citizens do not need to get visas to travel to Japan…but maybe I am getting ahead of myself here:-)

Histogen and Replicel to present at Stem Cell Meeting on the Mesa

If you live anywhere near San Diego (now one of the world’s leading biotech hubs), the “Stem Cell Meeting on the Mesa” from October 7-9, 2014 is worth attending if you can somehow get in. Surprisingly, both Histogen (based in San Diego) and Replicel (based in Vancouver, Canada) are presenting at this event.  For more, scroll all the way down on this detailed descriptions page of each company’s presentation.  Histogen’s presentation will be given by CEO Gail Naughton and Replicel’s presentation will be given by CEO David Hall.  I wonder if these two competitors will talk to each other at lunch?

I do not expect either company’s hair loss research related presentation to divulge anything new or ground breaking. However, the overall conference is extremely interesting in terms of the incredible advances that are now being made in regenerative medicine, gene therapy, stem cell research and more.  Many of the speakers are renowned leaders in their fields.

An interesting recent article on Replicel.